Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1CNS 1

Conditions

Testicular Neoplasms 22Testicular Germ Cell Tumor 15Ovarian Neoplasms 13Teratoma 11Endodermal Sinus Tumor 9Central Nervous System Neoplasms 9Sarcoma 8Carcinoma, Embryonal 8Kidney Neoplasms 7Wilms Tumor 6Seminoma 6Neuroectodermal Tumors, Primitive, Peripheral 6Carcinoma, Renal Cell 6Urinary Bladder Neoplasms 5Osteosarcoma 5Penile Neoplasms 4Ovarian Germ Cell Cancer 4Medulloblastoma 4Rhabdoid Tumor 3Retinoblastoma 3Optic Nerve Glioma 3Neuroblastoma 3Neoplasms 3Astrocytoma 3Urethral Neoplasms 2Teratoma, Testicular 2Sarcoma, Synovial 2Sarcoma, Endometrial Stromal 2Rhabdomyosarcoma 2Pheochromocytoma 2

Interventions

Paclitaxel 2pegfilgrastim 1Taxes 1Sunitinib 1Lapatinib 1Imatinib Mesylate 1Ifosfamide 1Cisplatin 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Dysgerminoma × Ifosfamide × Genitourinary × Clear all
NCT00470366 2017-11-28

Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
60 enrolled 11 charts
CNSGenitourinaryGynecologic

Testicular Germ Cell Tumor, Dysgerminoma, Ovarian Neoplasms, Teratoma, Testicular Neoplasms, Central Nervous System Neoplasms, Carcinoma, Embryonal, Seminoma, Endodermal Sinus Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡